Ligand profile
PNM
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_03128 — Beta-lactamase CTX-M-2
Identifiers
Database identifiers and provenance.
- Ligand ID
PNM- PDB
5kmw- UniProt (similar protein)
Q47066- Target protein
- KP13_03128
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 95.5
- −1 ≤ LogP ≤ 5 0.81
- MW ≤ 500 Da 336.4
- LogP ≤ 5 0.81
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 95.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC1([C@@H](N[C@H](S1)[C@@H](C=O)NC(=O)Cc2ccccc2)C(=O)O)CCC1([C@@H](N[C@H](S1)[C@@H](C=O)NC(=O)Cc2ccccc2)C(=O)O)C
InChI=1S/C16H20N2O4S/c1-16(2)13(15(21)22)18-14(23-16)11(9-19)17-12(20)8-10-6-4-3-5-7-10/h3-7,9,11,13-14,18H,8H2,1-2H3,(H,17,20)(H,21,22)/t11-,13+,14-/m1/s1InChI=1S/C16H20N2O4S/c1-16(2)13(15(21)22)18-14(23-16)11(9-19)17-12(20)8-10-6-4-3-5-7-10/h3-7,9,11,13-14,18H,8H2,1-2H3,(H,17,20)(H,21,22)/t11-,13+,14-/m1/s1
OGFZUTGOGYUTKZ-KWCYVHTRSA-NOGFZUTGOGYUTKZ-KWCYVHTRSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00144' 'PF00905' 'PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand PNM →
- PDB RCSB structure 5kmw →
- UniProt UniProt Q47066 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “PNM”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03128.
PDB 51
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 6
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).